Steven Cohen Recursion Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$9.13 - $15.52 $9.76 Million - $16.6 Million
-1,069,500 Reduced 72.75%
400,700 $3.99 Million
Q4 2023

Feb 14, 2024
BUY
$5.09 - $10.79 $6.78 Million - $14.4 Million
1,332,700 Added 969.24%
1,470,200 $14.5 Million
Q3 2023

Nov 14, 2023
BUY
$6.59 - $15.86 $906,125 - $2.18 Million
137,500 New
137,500 $1.05 Million

Others Institutions Holding RXRX

# of Institutions
289
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.18B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email